A lipid core peptide construct containing a conserved region determinant of the group A streptococcal M protein elicits heterologous opsonic antibodies

Infection and Immunity

Volumn 70, Issue 5, 2002, Pages 2734-2738

  Olive, Colleen ^a   Batzloff, Michael R ^a   Horváth, Anikó ^a   Wong, Allan ^a   Clair, Timothy ^a   Yarwood, Penny ^a   Toth, Istvan ^a   Good, Michael F ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; FREUND ADJUVANT; IMMUNOGLOBULIN G; LIPID; OPSONIN;

AMINO ACID SEQUENCE; ANTIBODY TITER; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; NONHUMAN; OPSONIZATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONFORMATION; STREPTOCOCCUS GROUP A;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; CARRIER PROTEINS; FEMALE; IMMUNIZATION; IMMUNOGLOBULIN G; MICE; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; STREPTOCOCCAL VACCINES; STREPTOCOCCUS PYOGENES; VACCINES, SYNTHETIC;

EID: 0036124084     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.70.5.2734-2738.2002     Document Type: Article

References (28)

1. Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees
2. Influence of intranasal immunization with synthetic peptides corresponding to conserved epitopes of M protein on mucosal colonization by group A streptococci
3. Synthetic peptide vaccine against mucosal colonization by group A streptococci. I. Protection against a heterologous M serotype with shared C repeat region epitopes
4. Novel multi-epitope strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population
5. Epitopes of group A streptococcal M protein that evoke cross-protective local immune responses
6. Multiple, heart-cross-reactive epitopes of streptococcal M proteins
7. Recombinant tetravalent group A streptococcal M protein vaccine
8. Recombinant, octavalent group A streptococcal M protein vaccine
9. In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine
10. Streptococcal M protein: Molecular design and biological behavior
11. Cross-reactivity between streptococcus and human tissue: A model of molecular mimicry and autoimmunity
12. Lipidic peptides I. Synthesis resolution and structural elucidation of fatty amino acids and their homo- and heterooligomers
13. T-cell reactivity against streptococcal antigens in the periphery mirrors reactivity of heart-infiltrating T lymphocytes in rheumatic heart disease patients
14. Mapping the minimal murine T cell and B cell epitopes within a peptide vaccine candidate from the conserved region of the M protein of group A streptococcus
15. Controlled lipidation and encapsulation of peptides as a useful approach to mucosal immunizations
16. Oral administration of an antigenic synthetic lipopeptide (MAP-P3C) evokes salivary antibodies and systemic humoral and cellular responses
17. Towards a vaccine for rheumatic fever: Identification of a conserved target epitope on M protein of group A streptococci
18. Conserved T and B cell epitopes on the M protein of group A streptococci: Induction of bactericidal antibodies
19. Induction of autoimmune valvular heart disease by recombinant streptococcal M protein
20. Mapping a conserved conformational epitope from the M protein of group A streptococci
21. Group A streptococcal M protein: Virulence factors and protective antigens
22. In situ neutralization in Boc-chemistry solid phase peptide synthesis. Rapid, high yield assembly of difficult sequences
23. Enhancement of immunogenicity of synthetic peptide vaccines related to hepatitis in chemically defined models consisting of T- and B-cell epitopes
24. A combined adjuvant and carrier system for enhancing synthetic peptides immunogenicity utilizing lipidic amino acids
25. Immunological evaluation of the lipid-core-peptide (LCP) adjuvant/carrier system
26. Synthesis of the mitogenic S-[2,3-bis(palmitoyloxy)propyl]-N-palmitoylpentapeptide from Escherichia coli lipoprotein. Hoppe-Seyler's Z
27. Totally synthetic lipid-containing polyoxime peptide constructs are potent immunogens
28. Immunogenicity evaluation of a lipidic amino acid-based synthetic peptide vaccine for Chlamydia trachomatis